Central CYP1B1 (Cytochrome P450 1B1)-Estradiol Metabolite 2-Methoxyestradiol Protects From Hypertension and Neuroinflammation in Female Mice
Purnima Singh,Chi Young Song,Shubha Ranjan Dutta,Frank J. Gonzalez,Kafait U. Malik,Purnima SinghChi Young SongShubha Ranjan DuttaFrank J. GonzalezKafait U. MalikFrom the Department of Pharmacology,Addiction Science,and Toxicology,College of Medicine,University of Tennessee Health Science Center,Memphis (P.S.,C.Y.S.,S.R.D.,K.U.M.)Laboratory of Metabolism,National Cancer Institute,Bethesda,MD (F.J.G.).
DOI: https://doi.org/10.1161/HYPERTENSIONAHA.119.14548
IF: 9.8968
2020-03-10
Hypertension
Abstract:Previously, we showed that peripheral administration of 2-ME (2-methoxyestradiol), a CYP1B1 (cytochrome P450 1B1)-catechol- O -methyltransferase (COMT) generated metabolite of E2 (17β-Estradiol), protects against angiotensin II-induced hypertension in female mice. The demonstration that central E2 inhibits angiotensin II-induced hypertension, together with the expression of CYP1B1 in the brain, led us to hypothesize that E2-CYP1B1 generated metabolite 2-ME in the brain mediates its protective action against angiotensin II-induced hypertension in female mice. To test this hypothesis, we examined the effect of intracerebroventricularly (ICV) administered E2 in ovariectomized (OVX)-wild-type ( Cyp1b1 +/+ ) and OVX- Cyp1b1 −/− mice on the action of systemic angiotensin II. ICV-E2 attenuated the angiotensin II-induced increase in mean arterial blood pressure, impairment of baroreflex sensitivity, and sympathetic activity in OVX- Cyp1b1 +/+ but not in ICV-injected short interfering (si)RNA-COMT or OVX- Cyp1b1 −/− mice. ICV-2-ME attenuated the angiotensin II-induced increase in blood pressure in OVX- Cyp1b1 −/− mice; this effect was inhibited by ICV-siRNA estrogen receptor-α (ERα) and G protein-coupled estrogen receptor 1 (GPER1). ICV-E2 in OVX- Cyp1b1 +/+ but not in OVX- Cyp1b1 −/− mice and 2-ME in the OVX- Cyp1b1 −/− inhibited angiotensin II-induced increase in reactive oxygen species production in the subfornical organ and paraventricular nucleus, activation of microglia and astrocyte, and neuroinflammation in paraventricular nucleus. Furthermore, central CYP1B1 gene disruption in Cyp1b1 +/+ mice by ICV-adenovirus-GFP (green fluorescence protein)-CYP1B1-short hairpin (sh)RNA elevated, while reconstitution by adenovirus-GFP-CYP1B1-DNA in the paraventricular nucleus but not in subfornical organ in Cyp1b1 −/− mice attenuated the angiotensin II-induced increase in systolic blood pressure. These data suggest that E2-CYP1B1-COMT generated metabolite 2-ME, most likely in the paraventricular nucleus via estrogen receptor-α and GPER1, protects against angiotensin II-induced hypertension and neuroinflammation in female mice.
peripheral vascular disease